Drug Channels

JUNE 17, 2024

Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

DECEMBER 15, 2022

Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market. There’s a lot to unpack about the growing discount card market. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Marketing 98

Marketing Research Drugs Pharmacy 98

Drug Channels

JUNE 18, 2024

One important update to the figures below: We (and many others) had significantly underestimated Walgreens' revenues and market share. Consequently, its market share is closer to 10%, compared with the 3% that we reported. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

MAY 23, 2023

In 2022, the PBM market remained highly consolidated—although there were some intriguing share shifts among the largest players. Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

OCTOBER 8, 2021

Today’s guest post comes from Bill Dupere, Practice Lead and VP of Market Access Solutions and Eric Willis, VP of Operations Hub and Reimbursement Services at TrialCard. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. Read on for Bill’s and Eric’s insights. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Marketing Pharmacy Drugs 98

Drug Channels

JANUARY 28, 2022

It's a moderated discussion with payers on how the changing market might impact their management strategies in immunology. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. To learn more, sign up for MMIT’s Immunology Biosimilars webcast. d/b/a Drug Channels Institute.

Biosimilars 98

Biosimilars Marketing Drugs 98

Drug Channels

MAY 9, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. FYI, Managed Healthcare Executive (accurately) described my presentation as " mixing jokes with data and PowerPoint slides." Yes, that sounds about right. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 98

Specialty Pharmacies Marketing Pharmacy Drugs 98

Drug Channels

SEPTEMBER 8, 2021

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for his latest video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. Friday, September 24, 2021, from 12:00 p.m. to 1:30 p.m. d/b/a Drug Channels Institute.

Marketing 97

Marketing Biosimilars Drugs Hospitals 97

Drug Channels

JULY 12, 2022

For more on 340B and the specialty market, join me for my upcoming July 29 live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on for details and my commentary below. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

JUNE 6, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Full salary data below for your enjoyment or sorrow. As expected, the past few years have been highly challenging for retail-employed pharmacists. Expect further declines as the shakeout continues. d/b/a Drug Channels Institute. This Feed is for personal non-commercial use only.

Pharmacy 98

Pharmacy Hospitals Marketing Drugs 98

Drug Channels

MARCH 8, 2022

The total share of the largest 15 companies decreased slightly compared with their 2020 share, due primarily to below-market growth rates at retail and long-term care pharmacies. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. prescription dispensing revenues reached a record $501 billion in 2021.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

APRIL 4, 2023

Four crucial trends will deflate the gross-to-net bubble—thereby disrupting market access strategies, altering pharmacy benefit manager (PBM) profit models, and changing plan sponsor benefit designs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

JUNE 21, 2023

Four crucial trends will deflate the gross-to-net bubble—thereby disrupting market access strategies, altering pharmacy benefit manager (PBM) profit models, and changing plan sponsor benefit designs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Marketing 75

Marketing Pharmacy Drugs 75

Drug Channels

APRIL 18, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. While this is a longer-than usual post, I can still only barely scratch the surface of the many far-reaching effects of this legislation. As always, I encourage you to share your own thoughts in the comments below or on social media. d/b/a Drug Channels Institute.

Marketing 98

Marketing Pharmacy Drugs 98

Drug Channels

MARCH 8, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Find out at my upcoming live video webinar, Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook , on March 31, 2023, from 12:00 p.m. to 1:30 p.m. Click here to learn more and sign up. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

OCTOBER 6, 2020

The biosimilar market is finally beginning to fulfill its promise. What’s more, manufacturers of reference products are cutting drug prices to defend their market shares. What’s more, manufacturers of reference products are cutting drug prices to defend their market shares. As you will see below, Dr. Gottlieb was right.

Biosimilars 52

Biosimilars Marketing Regulations FDA 52

Drug Channels

JUNE 20, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. While this is a longer-than usual post, I can still only barely scratch the surface of the many far-reaching effects of this legislation. As always, I encourage you to share your own thoughts in the comments below or on social media. d/b/a Drug Channels Institute.

Marketing 98

Marketing Pharmacy Drugs 98

Drug Channels

OCTOBER 24, 2023

The 2024 data provide early evidence of a shrinking PDP market. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. In upcoming articles, I’ll delve into chain and independent pharmacies’ participation in the major 2024 preferred networks. d/b/a Drug Channels Institute.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

SEPTEMBER 24, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Update: Buy-and-Bill Market Trends. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. Click here to see the original post and comments from June 2021. d/b/a Drug Channels Institute.

Hospitals 90

Hospitals Marketing Drugs Pharmacy 90

Drug Channels

DECEMBER 17, 2020

The biosimilar market is finally beginning to fulfill its promise. What’s more, manufacturers of reference products are cutting drug prices to defend their market shares. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. HHS relied in part on a highly misleading ASPE study of 2018 data.

Biosimilars 52

Biosimilars Marketing Regulations FDA 52

Drug Channels

MAY 9, 2024

To learn more about navigating the complexities of market access, contact MMIT and its sister company, The Dedham Group. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. They discuss five ways manufacturers can prevent these barriers from affecting patients. Read on for their insights.

Therapies 98

Therapies Marketing Drugs 98

Drug Channels

OCTOBER 28, 2021

Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. To learn more about technology and access to specialty medications, read the CoverMyMeds Medication Access Report: Complex Care & Specialty Edition. Read on for Megan’s insights. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Marketing 75

Marketing Drugs 75

Drug Channels

JULY 11, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Manufacturers’ contract pharmacy policy changes have slowed profits at pharmacies and PBMs, while triggering change in hospitals’ pharmacy strategies. Read on for my latest effort to pierce these little webs of 340B opacity. d/b/a Drug Channels Institute.

Pharmacy 74

Pharmacy Marketing Hospitals Drugs 74

Drug Channels

MAY 2, 2024

Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Chris explains how the Inflation Reduction Act of 2022 (IRA) will impact hub, patient assistance programs (PAP), and affordability programs.

Marketing 98

Marketing Drugs 98

Drug Channels

JUNE 13, 2024

Today’s guest post comes from Christine Juday, Head of Market Access at Real Chemistry. Click here to learn more about Real Chemistry’s suite of market access consulting and payer/IDN marketing solutions. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Marketing 52

Marketing Research Drugs 52

Drug Channels

FEBRUARY 2, 2024

Today’s guest post comes from Divya Iyer, SVP of Go-to-Market Strategy at GoodRx. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Divya shares highlights from GoodRx’s new research report: The GoodRx Effect: How GoodRx Improves the Economics of Healthcare. Read on for Divya’s insights.

Therapies 98

Therapies Marketing Research Drugs 98

Drug Channels

JANUARY 4, 2024

HMP is a leading omnichannel healthcare education, events, and market insights company. Here’s the press release: HMP Global Expands Market Reach with Strategic Acquisition of Drug Channels Institute; Launches Market Intelligence Unit Paula and I will continue to lead DCI as part of HMP. It’s a great fit for DCI.

Drugs 97

Drugs Marketing 97

Drug Channels

OCTOBER 12, 2023

To learn more, join Chris Dowd, Senior Vice President of Market Development at ConnectiveRx, for a free webinar on October 26th at 1:00 pm ET: The Battle Over Accumulators and Maximizers: What You Need to Know for 2024. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Read on for Sam’s insights.

Marketing 98

Marketing Drugs 98

Drug Channels

AUGUST 25, 2023

Today’s guest post comes from Chris Dowd, Senior Vice President of Market Development at ConnectiveRx. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Chris discusses how such copay adjustment programs as accumulators and maximizers impact patients. Read on for Chris’ insights. d/b/a Drug Channels Institute.

Marketing 98

Marketing Drugs 98

Drug Channels

JUNE 24, 2024

Our fireside chats will illuminate crucial issues and key strategic concerns affecting the prescription drug market and the entire U.S. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. healthcare system. The event will also include panel discussions covering a range of important topics.

Drugs 52

Drugs Marketing 52

Drug Channels

APRIL 7, 2023

Today’s guest post comes from Heather Roulston, Market Research Manager at MMIT. For additional market insights, click here to learn about MMIT’s Biologics & Injectables Index. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Heather also shares data on payers’ site-of-care management strategies.

Marketing 98

Marketing Production Research Drugs 98

Drug Channels

SEPTEMBER 9, 2020

Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. I review: The role of specialty drugs in the pharmacy industry Our latest data on specialty pharmacy accreditation Commentary on PBM’s role in the specialty industry The data are drawn from our 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Drugs 52

Drug Channels

JUNE 18, 2024

See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to see the original post from April 2024. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Marketing 52

Drug Channels

SEPTEMBER 15, 2023

Nicole summarizes MMIT’s research on payers’ views of two crucial market changes: (1) the Inflation Reduction Act of 2022’s requirement to cap insulin prices at $35 for Medicare beneficiaries, and (2) manufacturers’ reduction in list prices for certain insulin products. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Production 97

Production Research Marketing Drugs 97

Drug Channels

MAY 18, 2021

Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. However, pharmacy locations owned by healthcare providers—hospitals, health systems, physician practices, and providers’ group purchasing organizations—now account for nearly 40% of all accredited specialty pharmacy locations. Read on for a bite of our arithmomania.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. As always, Dr. Please note that Dr. Fein will focus on the IRA’s patient and commercial market impacts.

Pharmacy 98

Pharmacy Biosimilars Drugs Marketing 98

Drug Channels

JULY 13, 2023

He describes SingleCare's new Pharma Solutions, which offers manufacturers the opportunity to market their copay assistance programs directly to SingleCare's millions of monthly prescription discount users. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Read on for Josh’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs 98